---
title: "Century released its first-quarter performance, with a net loss attributable to the parent company of 19.559 million yuan, narrowing by 71.14%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238062209.md"
description: "According to the Zhitong Finance APP, Century released its first-quarter report for 2025, showing that the company's operating revenue was 409 million yuan, a year-on-year increase of 105.78%. The net loss attributable to shareholders of the listed company was 19.559 million yuan, a year-on-year narrowing of 71.14%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 29.473 million yuan, a year-on-year narrowing of 56.91%. The basic loss per share was 0.02 yuan"
datetime: "2025-04-29T12:51:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238062209.md)
  - [en](https://longbridge.com/en/news/238062209.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238062209.md)
---

# Century released its first-quarter performance, with a net loss attributable to the parent company of 19.559 million yuan, narrowing by 71.14%

According to the Zhitong Finance APP, Century (300078.SZ) released its first-quarter report for 2025, showing an operating income of 409 million yuan, a year-on-year increase of 105.78%. The net loss attributable to shareholders of the listed company was 19.559 million yuan, a year-on-year narrowing of 71.14%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 29.473 million yuan, a year-on-year narrowing of 56.91%. The basic loss per share was 0.02 yuan

### Related Stocks

- [300078.CN](https://longbridge.com/en/quote/300078.CN.md)

## Related News & Research

- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [Flexdeal chair Alberto Amaral buys EUR 150,000 in shares](https://longbridge.com/en/news/296250174.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)
- [08:48 ETLanguageLine TranslateExpress Now Available in the Epic Toolbox](https://longbridge.com/en/news/296230987.md)
- [CONX delays Q2 10-Q filing, expects to miss SEC extension deadline](https://longbridge.com/en/news/295972084.md)